The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Amarin Corp. PLC  (AMRN) Trade Now »     Rate AMRN  -  Discuss AMRN  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
77.0%
Top:
0.0%
Rate AMRN:



AMRN Analysis & Videos »


AMRN: Bull or Bear?





BioRunUp's Pick of AMRN up 130% / Now Offering New $49 Monthly Plan Graphic_rating_buy AMRN
Mikerun
73%
 +20.64%
in 932 days
<>
In celebration of our pick, AMRN, surging over 130% since our first mention we are offering a new re-occurring monthly plan for new subscribers, priced at only $49.95 a month.  This plan is backed with a 100% satisfaction guarantee, cancel at any time to receive a full refund on your current month.  We still offer an annual plan at $295, act quickly, as the annual plan will be rising to $495 on January 1, 2010.

Take a look at some emails/messages we have received just from this morning regarding our pick of AMRN:

Cole:
<> <>  "I <><>< /><><><><><><><>< /><><><><><><><>< /><><><><><><><><><><><><><><><><><><><><><><><>< /><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>< /><><>...
By  Mike Havrilla   (+1.04%  risk: moderate)  11/29/10 99 comments


Get free stock alert for AMRN:
Your Email Address:


Trading FDA, Clinical Trial Binary Events: $AMRN $DDSS $FOLD Graphic_rating_buy AMRN
Mikerun
73%
 +140.21%
in 114 days
(closed on 11/29/10)
Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news...

<font> Amarin Corp. (NASDAQ:AMRN) has a conference call scheduled for Tuesday 10-August at 11am (ET) and plans to provide an update on its financials and a progress update on the two ongoing pivotal Phase 3 studies (MARINE and ANCHOR) for AMR101 as a purified, prescription-grade omega-3 fatty acid compound that is being evaluated for the treatment of high triglycerides. </font>

<> <font> The MARINE study was last updated on 9-June in the ClinicalTrials.gov database (stu...
By  Mike Havrilla   (+1.04%  risk: moderate)  08/07/10 126 comments


Trading FDA, Clinical Trial Binary Events: $ANDS $BNVI $AMRN $EXAS Graphic_rating_buy AMRN
Mikerun
73%
 +4.21%
in 9 days
(closed on 08/07/10)
Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news...

<font> Anadys Pharma (NASDAQ:ANDS) announced that six patients (100%) receiving 200mg twice daily of ANA598 (a direct-acting anti-viral agent against hepatitis C virus or HCV) maintained undetectable levels of HCV at 12-weeks post-treatment (Sustained Virological Response 12 or SVR12). Additional post-treatment results from other treatment arms in the ongoing Phase 2 study are expected later this year. </font>

<> <font> Bionovo (NASDAQ:BNVI) announced today that it recei...
By  Mike Havrilla   (+1.04%  risk: moderate)  07/29/10 73 comments


Trading FDA, Clinical Trial Binary Events: Why Amarin (NASDAQ:AMRN) is My Top Buy Graphic_rating_buy AMRN
Mikerun
73%
 -7.20%
in 34 days
(closed on 07/29/10)
Amarin Corp. (NASDAQ:AMRN) is developing AMR101 (Ethyl-EPA) as a prescription-grade omega-3 fatty acid that has been marketed in Japan for over 10 years as EPADEL by Mochida Pharma. Ethyl-EPA is differentiated from Glaxo's (NYSE:GSK) $1 billion dollar product LOVAZA (omega-3-acid ethyl esters) in the following key areas:

<font> - no fishy smell / taste or GI side effects such as burping = better patient compliance since these are both taken every day </font>

<font> - lacks Ethyl-DHA omega-3 fatty acid component, which can raise bad cholesterol (LDL) levels </font>

<> <font> -...
By  Mike Havrilla   (+1.04%  risk: moderate)  06/25/10 119 comments


Bullish on AMRN ... Graphic_rating_buy AMRN
Foto
62%
 +444.80%
in 1454 days
Amarin Corporation plc Healthcare Drug Manufacturers - Other Ireland 35.71M - 1.25 -5.30%
By  Marian Filo   (-24.55%  risk: aggressive)  06/25/09 36 comments


Bullish on AMRN ... Graphic_rating_buy AMRN
100pureveg
29%
 +998.39%
in 2232 days
AMRN will soar.
It is an excellent company in R& D of neuroscience drugs.
They have a bright future considering the big-boom in baby-boomer population within the next few years...The price is already rock-bottom, can't go any more downhill.
Buy now, enjoy later !
By  Hemant A. Sonawane   (+14.71%  risk: aggressive)  05/08/07 Comment


Get free stock alert for AMRN:
Your Email Address:


Don't be nervous... Graphic_rating_buy AMRN
100pureveg
29%
 +0.00%
in 0 minute
(closed on 05/08/07)

AMRN will soar.

It is an excellent company in R& D of neuroscience drugs.

They have a bright future considering the big-boom in baby-boomer population within the next few years...The price is already rock-bottom, can't go any more downhill.

Buy now, enjoy later !

By  Hemant A. Sonawane   (+14.71%  risk: aggressive)  05/08/07 24 comments


80% price drop. Buy it!!! Graphic_rating_buy AMRN
Galactica_aim_008
59%
 +796.05%
in 2246 days
Holy crap. Well I was wrong. I guess I should stick to analyzing long trends, and not biotech stocks. This is undervalued however and will swing up hard.
By  stealthgear   (+2.24%  risk: aggressive)  04/24/07 27 comments


Amarin Corp Graphic_rating_buy AMRN
Galactica_aim_008
59%
 +10.14%
in 11 hours
(closed on 04/24/07)
Some nice Grzzzowth. Below its 2 day high. Gonna spike again.
By  stealthgear   (+2.24%  risk: aggressive)  04/24/07 25 comments


AMRN is growing in a good market Graphic_rating_buy AMRN
Leaf2invert
70%
 +161.92%
in 2284 days
- A few drugs at end of pipeline (MS drug could be huge)
- They work on diseases with big $$$ potential
- Volume is huge lately
- Made money on this stock already, hoping it increases
- Making smart personnel decisions
By  Ferarapan   (+32.00%  risk: aggressive)  03/17/07 26 comments





People Bullish on AMRN

Mikerun
Mike Havrilla
Principal
73%
over 2 years ago

450vampyr_avatar-med
supratrader
Principal
N/A
over 3 years ago

sh0efalue
Analyst
N/A
over 3 years ago

Foto
Marian Filo
Principal
62%
over 3 years ago

Stephen M
Analyst
N/A
over 5 years ago


People Bearish on AMRN

Impact3
Yannis Maarten
Sr. Associate
80%
about 1 year ago

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +32.13% 538
2 Gerald Greene 18.14 +6.82% 289
3 stockmarketfunding.com 17.66 +22.47% 85
4 akiralegrand 13.47 +13.86% 71
5 anup2104 12.13 +175.56% 106


POPULAR STOCKS
Symbol Company Name Sentiment
CSCO Cisco Systems Inc
AMZN Amazoncom Inc
MO Altria Group Inc
SBUX Starbucks Corp
MCD McDonald's Corp.
BIDU Baiducom Inc ADS

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on AMRN


Discussion Wall + Add  
finny  


More Resources

Graphic_arrow1 About Amarin Corp. PLC - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch